Yesterday, Medrio released a press release announcing the addition of MANA RBM to its Partnership Program. https://www.prweb.com/releases/2018/07/prweb15619842.htm
This exciting news means an efficient, cost effective, complete Risk Based Monitoring (RBM) solution and proven methods to meet the new ICHE6(R2) Good Clinical Practice Guidance are now available to companies of all sizes—within existing study budgets and timelines.
Whether you conduct the oversight yourself, or have MANA RBM conduct your data management and monitoring, MANA RBM’s complete RBM solution works to meet your needs..
“Our RBM Solution focuses on the most important aspects of the trial and provides the most comprehensive review of those areas—far exceeding the review performed by Source Data Verification”, reported Penelope Manasco, M.D., CEO of MANA RBM. “And we don’t stop with the systems—we provide our Sponsors with SOPs and Work Instructions to facilitate RBM implementation.”
“As Clinical Operations professionals, we believe trial oversight should include the same systematic, data-driven, evidence-based methods used in discovering new products. Clinical trials are the most important studies conducted in the lifecycle of a new treatment. We owe patients, their caregivers, and physicians our best efforts to pursue scientific rigor. Our complete RBM solution provides the tools and processes to achieve this goal”, said Dr. Manasco commenting on the Medrio press release.